Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry

Journal of Biological Inorganic Chemistry

Volumn 13, Issue 3, 2008, Pages 421-434

  Will, Joanna ^a   Sheldrick, William S ^a   Wolters, Dirk ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Anticancer drug; Cisplatin; DNA repair; Escherichia coli; Protein targets; Tandem mass spectrometry

Indexed keywords

BACTERIAL PROTEIN; CISPLATIN; DNA BINDING PROTEIN; DNA TOPOISOMERASE; FIMBRIA PROTEIN; HELICASE; PROTEIN MUTS; RIBOSOME PROTEIN; THIOREDOXIN 1;

ACIDITY; ALKALINITY; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG PROTEIN BINDING; ELECTROSPRAY MASS SPECTROMETRY; ESCHERICHIA COLI; LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TARGETING;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, LIQUID; CISPLATIN; DNA-BINDING PROTEINS; ESCHERICHIA COLI; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

ESCHERICHIA COLI;

EID: 40949124769     PISSN: 09498257     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00775-007-0333-8     Document Type: Article

References (71)

1. Einhorn EH (1997) Clin Cancer Res 3:2630-2632
2. Wong E, Giandomenico CM (1999) Chem Rev 99:2451-2466
3. Eastman A (1999) In: Lippert B (ed) Cisplatin, chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Weinheim, pp 111-134
4. Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467-2498
5. Brabec V (2002) Prog Nucleic Acid Res Mol Biol 71:1-68
6. Zamble DB, Lippard SJ (1995) Trends Biochem Sci 20:435-439
7. Mello JA, Trimmer EE, Kartalou M, Essigmann JM (1998) Nucleic Acids Mol Biol 12:249-274
8. Zdraveski ZZ, Mello JA, Marinus MG, Essigmann JM (2000) Chem Biol 7:39-50
9. Fourrier L, Brooks P, Malinge JM (2003) J Biol Chem 278:21267-21275
10. Salsbury Jr FR, Clodfelter JE, Gentry MB, Hollis T, Drotschmann Scarpinato K (2006) Nucleic Acids Res 34:2173-2185
11. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WGJ, Levrero M, Wang JY (1999) Nature 399:806-809
12. Zamble DB, Lippard SJ (1999) In: Lippert B (ed) Cisplatin, chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Weinheim, pp 73-110
13. Han MJ, Lee SY (2006) Microbiol Mol Biol Rev 70:362-439
14. Guo Z, Hambley TW, del Socorro Murdoch P, Sadler PJ, Frey U (1997) J Chem Soc Dalton Trans 469-478
15. Reedijk J (1999) Chem Rev 99:2499-2510
16. Sutton MD, Smith BT, Godoy VG, Walker GC (2000) Annu Rev Genet 34:479-497
17. Washburn MP, Wolters DA, Yates JP III (2001) Nat Biotechnol 19:242-247
18. Corbin RW, Paliy O, Yang F, Shabanowitz J, Platt M, Lyons Jr CE, Root K, McAuliffe J, Jordan MI, Kustu S, Soupene E, Hunt DF (2003) Proc Natl Acad Sci USA 100:9232-9237
19. Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK (2006) Chem Rev 106:2224-2248
20. Wolters DA, Washburn MP, Yates III JR (2001) Anal Chem 73:5683-5690
21. Will J, Kyas A, Sheldrick WS, Wolters DA (2007) J Biol Inorg Chem 12:883-894
22. Allardyce CS, Dyson PJ, Abou-Shakra FR, Birtwhistle H, Coffey J (2001) Chem Commun 2708-2709
23. Khalaila I, Bergamo A, Bussy F, Sava G, Dyson PJ (2006) Int J Oncol 29:261-268
24. Khalaika I, Allardyce CS, Verma CS, Dyson PJ (2005) Chembiochem 6:1788-1795
25. Watt GW, Cude WA (1968) Inorg Chem 7:335-338
26. Erickson LE, Erickson HL, Meyer TY (1987) Inorg Chem 26:997-999
27. Appleton TG, Pesch FJ, Wienken M, Menzer S, Lippert B (1992) Inorg Chem 31:4410-4419
28. Tab DL, Eng JK, Yates JR III (2001) In: James P (ed) Proteome research: mass spectrometry. Springer, Heidelberg, pp 125-142
29. Blattner FR, Plunkett G, Block CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MS, Rose DJ, Mau B, Shao Y (1997) Science 277:1453-1462
30. Roepstorff P, Fohlmann J (1984) Biomed Mass Spectrom 11:601-601
31. Appleton TG, Connor JW, Hall JR (1988) Inorg Chem 27:130-137
32. Fröhling CDW, Sheldrick WS (1997) J Chem Soc Dalton Trans 4411-4420
33. Barnham KJ, Djuran MI, del Socorro Murdoch P, Sadler PJ (1994) Chem Commun 721-722
34. Hahn M, Wolters D, Sheldrick WS, Hulsbergen FB, Reedijk J (1999) J Biol Inorg Chem 4:412-420
35. Chen Y, Guo Z, del Socorro Murdoch P, Zang E, Sadler PJ (1998) J Chem Soc Dalton Trans 1503-1508
36. Fröhling CDW, Sheldrick WS (1997) Chem Commun 1737-1738
37. Sovago I, Osz K (2006) Dalton Trans 32:3841-3854
38. Hahn M, Kleine M, Sheldrick WS (2001) J Biol Inorg Chem 6:556-566
39. Kleine M, Wolters D, Sheldrick WS (2003) J Inorg Biochem 97:354-363
40. Manka S, Becker F, Hohage O, Sheldrick WS (2004) J Inorg Biochem 98:1947-1956
41. Hohage O, Sheldrick WS (2006) J Inorg Biochem 100:1506-1513
42. Gatlin CL, Kleemann GR, Hays LG, Link AJ, Yates III JR (1998) Anal Biochem 263:93-101
43. Djuran MI, Lempers ELM, Reedijk J (1991) Inorg Chem 30:2648-2652
44. Allen GS, Zavialov A, Gursky P, Ehrenberg M, Frank J (2005) Cell 121:703-712
45. Bocharov EV, Gudkov AT, Arseniev AS (1996) FEBS Lett 379:291-294
46. Young CC, Bernlohr RW (1991) J Bacteriol 173:3096-3100
47. Xu J, Johnson RC (1995) J Bacteriol 177:3166-3175
48. Poulsen P, Jensen KF (1991) Res Microbiol 142:283-288
49. Legendre F, Chottard JC (1999) In: Lippert B (ed) Cisplatin, chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Weinheim, pp 223-245
50. Elkins CA, Nikaido H (2003) J Bacteriol 185:5349-5356
51. Nagakubo S, Nishino K, Harata T, Yamaguchi A (2002) J Bacteriol 184:4161-4167
52. Gibson D, Costello CE (1999) Eur J Mass Spectrom 5:501-510
53. Peleg-Shulman T, Najajreh Y, Gibson D (2002) J Inorg Biochem 91:306-311
54. Mandal R, Li X-F (2006) Rapid Commun Mass Spectrom 20:48-52
55. Calderone V, Casini A, Mangani S, Messori L, Orioli PL (2006) Angew Chem Int Ed 45:1267-1269
56. Visse R, King A, Moolenaar GF, Goosen N, van de Putte P (1994) Biochemistry 33:9881-9888
57. Aoe K, Kiura K, Ueoka H, Tabata M, Chikamori M, Kohara H, Harada M, Tanimoto M (2004) Anticancer Res 24:3893-3897
58. Matsumura T, Takigawa N, Kiura K, Shibayama T, Chikamori M, Tabata M, Ueoka H, Tanimoto M (2005) In Vivo 19:717-721
59. Irving JA, Hall AG (2001) Expert Rev Anticancer Ther 1:149-158
60. Lamers MH, Perrakis A, Enzlin JH, Winterwerp HHK, de Wind N, Sima TK (2000) Nature 407:711-717
61. Diges CM, Uhlenbeck OC (2001) EMBO J 20:5503-5512
62. Biaglow JE, Miller RA (2005) Cancer Biol Ther 4:6-13
63. Ott I, Gust R (2007) Arch Pharm 340:117-126
64. Arnold NB, Ketterer K, Kleeff J, Friess H, Buechler MW, Korc M (2004) Cancer Res 64:3599-3606
65. Katti SK, le Master DM, Eklund H (1990) J Mol Biol 212:167-184
66. Kato M, Yamamoto H, Okamura T-A, Maoka N, Masui R, Kuramitsu S, Ueyama N (2005) Dalton Trans 1023-1026
67. Arner ESJ, Nakamura H, Sasada T, Yodoi J, Holmgren A, Spyrou G (2001) Free Radic Biol Med 31:1170-1178
68. Liu H, Sadygov RG, Yates III JR (2004) Anal Chem 76:4193-4201
69. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M (2005) Mol Cell Proteomics 4:1265-1272
70. Lu P, Vogel C, Wang R, Yao X, Marcotte EM (2007) Nat Biotechnol 25:117-124
71. Neidhardt FC, Umbarger HE (1996) In: Neidhardt FC (ed) Escherichia coli and Salmonella typhimurium: cellular and molecular biology, vol 1, 2nd edn. ASM, Washington, DC, pp 13-16